I agree the past doesn't justify the current SP, but the direction and potential future does. I think LJ has done a very good job since taking over and the market is starting to agree.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025